What is the equity of Sysmex this year?
Sysmex has equity of 432.05 B JPY this year.
Sysmex Equity 2024
Sysmex Equity
432.05 B JPY
Ticker
6869.T
ISIN
JP3351100007
WKN
897966
In 2024, Sysmex's equity was 432.05 B JPY, a 24.04% increase from the 348.3 B JPY equity in the previous year.
Sysmex Aktienanalyse
What does Sysmex do?
Sysmex Corp is a Japanese company that has been a leading provider of diagnostic and analytical laboratory systems and solutions for the healthcare industry since its founding in 1968. The company is headquartered in Kobe, Japan and employs over 9,000 people worldwide. History: Sysmex was founded by a group of young scientists in Japan who wanted to develop an automated blood cell analysis system to improve the high workload of manual blood analysis at the time. The company began developing this system and brought it to market in 1972. Business model: Sysmex focuses on the development, production, and sale of diagnostic systems and solutions for medical laboratories around the world. The company specializes in hematology, hemoglobinopathy, hemostasis, urinalysis, immunology, clinical chemistry, and molecular biology. Divisions: Sysmex Corp is divided into three main business divisions: 1. Diagnostic Systems: This division includes hematology, hemoglobinopathy, hemostasis, urinalysis, immunology, clinical chemistry, and molecular biology systems. Sysmex is one of the world's leading providers of hematology analysis devices and also offers molecular biology systems for the diagnosis and monitoring of infectious diseases and cancer. 2. Information Solutions: This division offers software and IT solutions that support laboratory management and the integration of laboratory data to optimize analysis processes. The company also offers solutions for automating laboratory processes and managing laboratory inventory. 3. Life Science: This division focuses on the development of products for the life sciences, particularly cell analysis and imaging, as well as production, processing, and storage of cell cultures. Sysmex is also involved in the production of devices for harvesting mesenchymal stem cells from adipose tissue. Products: Sysmex offers a variety of products, including: - Hematology analysis devices for determining blood cell parameters such as RBC, WBC, HGB, HCT, and platelets. - Hemostasis systems for analyzing blood coagulation. - Molecular biology systems for the diagnosis and monitoring of infectious diseases and cancer. - Urinalysis systems for analyzing urine samples for chemical and microscopic parameters. - Immunology analysis devices for determining specific proteins and antibodies in the blood. - Clinical chemistry analysis devices for analyzing chemical parameters in blood samples. - Software and IT solutions for optimizing laboratory processes and management. - Cell analysis and imaging systems for investigating cell morphology and functions. - Devices for harvesting mesenchymal stem cells from adipose tissue. In summary, Sysmex Corp is a global leader in diagnostic and analytical laboratory systems and solutions for the healthcare industry. In its nearly 50-year history, the company has developed and produced a wide range of products that enable laboratories to perform fast and accurate disease diagnosis. The company has also expanded its business into other areas such as information solutions and the life sciences. Sysmex ist eines der beliebtesten Unternehmen auf Eulerpool.com.Equity Details
Analyzing Sysmex's Equity
Sysmex's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Sysmex's equity is essential for assessing its financial health, stability, and value to shareholders.
Year-to-Year Comparison
Evaluating Sysmex's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.
Impact on Investments
Sysmex's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.
Interpreting Equity Fluctuations
Fluctuations in Sysmex’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.
Frequently Asked Questions about Sysmex Stock
What was the equity of Sysmex compared to the previous year?
The equity of Sysmex has increased/decreased by 24.04% increased compared to the previous year.
What impact does a high equity have on investors of Sysmex?
A high equity is advantageous for investors of Sysmex as it is an indicator of the company's financial stability and its ability to manage risks and challenges.
What impact does low equity have on investors of Sysmex?
A low equity can be a risk for investors of Sysmex, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.
How does an increase in equity of Sysmex affect the company?
An increase in equity of Sysmex can strengthen the company's financial position and improve its ability to make investments in the future.
How does a reduction in the equity of Sysmex affect the company?
A reduction in equity of Sysmex can affect the financial situation of the company and lead to a higher dependence on debt capital.
What are some factors that influence the equity of Sysmex?
Some factors that can affect the equity of Sysmex include profits, dividend payments, capital increases, and acquisitions.
Why is the equity of Sysmex so important for investors?
The equity of Sysmex is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.
What strategic measures can Sysmex take to change the equity?
To change equity, Sysmex can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.
How much dividend does Sysmex pay?
Over the past 12 months, Sysmex paid a dividend of 29 JPY . This corresponds to a dividend yield of about 1.13 %. For the coming 12 months, Sysmex is expected to pay a dividend of 28.62 JPY.
What is the dividend yield of Sysmex?
The current dividend yield of Sysmex is 1.13 %.
When does Sysmex pay dividends?
Sysmex pays a quarterly dividend. This is distributed in the months of October, April, October, April.
How secure is the dividend of Sysmex?
Sysmex paid dividends every year for the past 23 years.
What is the dividend of Sysmex?
For the upcoming 12 months, dividends amounting to 28.62 JPY are expected. This corresponds to a dividend yield of 1.12 %.
In which sector is Sysmex located?
Sysmex is assigned to the 'Health' sector.
Wann musste ich die Aktien von Sysmex kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Sysmex from 12/1/2024 amounting to 15 JPY, you needed to have the stock in your portfolio before the ex-date on 9/27/2024.
When did Sysmex pay the last dividend?
The last dividend was paid out on 12/1/2024.
What was the dividend of Sysmex in the year 2023?
In the year 2023, Sysmex distributed 55.333 JPY as dividends.
In which currency does Sysmex pay out the dividend?
The dividends of Sysmex are distributed in JPY.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Sysmex
Our stock analysis for Sysmex Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Sysmex Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
